Table 1 Correlation of clinicopathological findings and Met expression

From: Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma

Patient characteristics ( n =145)

Overall

Low Met expression ( N =67)

High Met expression ( N =78)

P -value

Median age (range)

67 (35–85)

67 (35–83)

68 (44–85)

0.493

Sex

 Male (%)

120 (83%)

63 (94%)

57 (73%)

0.435

Tumour characteristics

T stagea

   

0.017

T1

44 (30%)

29 (43%)

15 (19%)

 

T2

18 (12%)

8 (12%)

10 (13%)

 

T3

83 (57%)

30 (45%)

53 (68%)

 

N stageb

   

0.001

N0

65 (45%)

38 (57%)

27 (35%)

 

N1

80 (55%)

29 (43%)

51 (65%)

 

M stagec

   

0.086

M0

122 (84%)

58 (87%)

64 (82%)

 

M1a

23 (16%)

9 (13%)

14 (18%)

 

Differentiation grade

   

0.078

 Good

11 (8%)

5 (7%)

6 (8%)

 

 Moderate

56 (39%)

35 (52%)

21 (27%)

 

 Poor

78 (54%)

27 (40%)

51 (65%)

 

Overall 5-year survival

35%

57%

16%

0.001

Disease-specific 5-year survival

48%

66%

33%

0.001

  1. aT1, tumour limited to (sub)mucosa; T2, tumour infiltrates muscularis propia; T3, tumour infiltrates adventitia layer; as determined in the pathological resection specimens.
  2. bN0, no tumour positive locoregional lymph nodes; N1, locoregional lymph node metastasis.
  3. cM0, no distant metastasis, M1a, metastasis in coeliac lymph nodes.